Development of advantus™(imidacloprid) soft chewable tablets for the treatment of Ctenocephalides felis infestations on dogs

Particle and Fibre Toxicology

Kathleen G. Palma¹  William R. Everett²  Tariq Qureshi³ 

[1] Piedmont Animal Health LLC, Greensboro 27410, NC, USA;BerTek, Inc., Greenbrier 72058, AR, USA;Bayer HealthCare, LLC, Animal Health Division, Shawnee Mission 66201-0390, KS, USA

关键词: Canine;    Fleas;    Ctenocephalides felis;    Soft chews;    Oral;    Advantus;    Imidacloprid;   

Others  :  1222130
DOI  :  10.1186/s13071-015-1020-1

 received in 2015-04-22, accepted in 2015-07-25,  发布年份 2015

【 摘 要 】

Background

Studies reported here were conducted to evaluate the safety and effectiveness of advantus™ (imidacloprid) soft chewable tablets for the treatment of flea (Ctenocephalides felis) infestations on dogs and puppies 10 weeks of age or older and weighing 4 pounds or greater.

Methods

A pharmacokinetic study was conducted to evaluate parameters of orally administered imidacloprid. A dose confirmation study was conducted to confirm the efficacy of 0.75 mg/kg at 8, 12 or 24 hours post-treatment. A knockdown and speed of kill study was conducted to confirm the efficacy of 0.75 mg/kg dose at 0.5, 1, 4 or 24 hours post-treatment. The safety of a daily dose administered for six months at approximately 1, 3, and 5 times the maximum exposure dose of 3.75 mg/kg was evaluated in puppies. A field study was conducted to evaluate the safety and efficacy of a daily oral dose of 0.75 mg/kg for 14 days in client-owned dogs.

Results

The pharmacokinetic parameters of the final imidacloprid oral formulation were; T _max1.31 hours, C _max690.0 ng/mL, AUC 2615.5 h*ng/mL and half-life was 2.2 hours.

The efficacy of 0.75 mg/kg BW was 98.6 %, 99.9 % and 100 % at 8, 12 and 24 hours post-treatment, respectively. The live flea counts were significantly different (p < 0.0001) and the treatment was well tolerated.

The flea counts at 1 hour post-treatment were significantly lower in the treated group and the speed of kill efficacy was 96.6 % at 4 hours post-treatment in the knockdown and speed of kill study.

The target animal safety study showed that the advantus™ soft chewable tablets administered orally to 10-week-old puppies once daily for 6 months at approximately 1, 3 and 5 times the maximum dose of 3.75 mg/kg was well tolerated and did not produce clinically relevant findings in Beagles.

In the field study, efficacy of the soft chewable tablets administered daily for 14 days to flea-infested dogs was 98.2 %.

Conclusion

Imidacloprid administered orally as a soft chewable tablet for the treatment of fleas on dogs was safe and highly effective with a rapid knockdown effect and rapid elimination.

【 授权许可】

   
2015 Qureshi et al.

【 图 表 】

Fig. 1.

【 参考文献 】

• [1]Durden LA, Hinckle NC. Fleas (Siphonaptera). Mullen G and Durden LA, editors. Medical and Veterinary Entomology. Elsevier. 2009:p.115-135
• [2]Conboy G. Cestodes of dogs and cats. Vet Clin North Am Small Anim Pract. 2009; 39:1075-1090.
• [3]Little S, Starkey L. Conquering Fleas: Preventing infestations & limiting disease transmission. Today’s Vet Prac. 2012;Nov/Dec:33–38.
• [4]Shaw SE, Day MJ, Birtles RJ, Breitschwerdt EB. Tick-borne diseases of dogs. Trends Parasitol. 2001; 17:74-80.
• [5]Rust MK. Advances in the control of Ctenocephalides felis (cat flea) on cats and dogs. Trends Parasitol. 2005; 21:232-236.
• [6]Arther RG, Cunningham J, Dorn H, Everett R, Herr LG, Hopkins T. Efficacy of imidacloprid for the removal and control of fleas (Ctenocephalides felis) on Dogs. Am. J. Vet Res. 1997; 58:848-850.
• [7]Buckingham S, Lapied B, Corronc H, Sattelle F. Imidacloprid actions on insect neuronal acetylcholine receptors. J Exp Biol. 1997; 200:2685-92.
• [8]Dryden MW, Denenberg TM, Bunch S. Control of fleas on naturally infested dogs and cats and in private residences using topical spot applications of fipronil or imidacloprid. Vet Parasitol. 2000; 93:69-75.
• [9]Everett R, Cunningham J, Arther R, Bledsoe DL, Mencke N. Comparative evaluation of the speed of flea kills of imidacloprid and selamectin on dogs. Vet Ther. 2000; 1:229-234.
• [10]Matsuda K, Shimomura M, Kondo Y, Ihara M, Hashigami K, Yoshida N et al.. Role loop D of the α7 nicotinic acetylcholine receptor in its interaction with the insecticide imidacloprid and related neonicotinoids. British J Pharmacol. 2000; 130:981-6.
• [11]Arther RG, Cunningham J, Everett R. Evaluating the effects of shampooing or repeated water exposure on the residual efficacy of Advantage® (imidacloprid) for flea control on dogs. Proc 4th Int Symp Ecto paras Pets, Riverside, CA; 1997.
• [12]Cunningham J, Everett R, Arther RG. Effects of shampooing or water exposure on the initial and residual efficacy of imidacloprid. Suppl Comp Cont Educ Pract Vet. 1997; 19:29-30.
• [13]Young DR, Arther RG, Davis WL. Evaluation of K9 Advantix™ vs. Frontline Plus® topical treatments to repel Brown Dog Ticks (Rhipicephalus sanguineus) on dogs. Parasitol Res. 2003; 90:S116-S118.
• [14]Epe C, Coati N, Stanneck D. Efficacy of the compound preparation imidacloprid 10 % (w/v) / permethrin 50 % (w/v) spot-on against ticks (I. ricinus, R. sanguineus) and fleas (C. felis) on dogs. Parasitol Res. 2003; 90:S122-S124.
• [15]Mencke N, Volf P, Volfova V, Stanneck D. Repellent efficacy of a combination containing imidacloprid and permethrin against sand flies (Phlebotomus papatasi) on dogs. Parasitol Res. 2003; 90:S108-S111.
• [16]Arther RG, Bowman DD, Slone RL, Travis LE. Imidacloprid plus moxidectin topical solution for the prevention of heartworm disease (Dirofilaria immitis) in dogs. Parasitol Res. 2005; 97:S76-S80.
• [17]Von Samson-Himmelstjerna G, Epe C, Schimmel A, Heine J. Larvicidal and persistent efficacy of an imidacloprid and moxidectin topical formulation against endoparasites in cats and dogs. Parasitol Res. 2003; 90:S114-S115.
• [18]Krieger K, Heine J, Dumont P, Hellmann K. Efficacy and safety of imidacloprid 10 % plus moxidectin 2.5 % spot-on in the treatment of sarcoptic mange and otoacariosis in dogs: results of a European field study. Parasitol Res. 2005; 97:S81-S88.
• [19]Heine J, Krieger K, Dumont P, Hellmann K. Evaluation of the efficacy and safety of imidacloprid 10 % plus moxidectin 2.5 % spot-on in the treatment of generalized demodicosis in dogs: results of a European field study. Parasitol Res. 2005; 97:S89-S96.
• [20]Fourie LJ, Kok DJ, Heine J. Evaluation of the efficacy of an imidacloprid 10 %/moxidectin1 % spot-on against Otodectes cynotis in cats. Parasitol Res. 2003;90:S112–3.
• [21]Ross DH, Arther RG, von Simson C, Doyle V, Dryden MW. Evaluation of the efficacy of topically administered imidacloprid + pyriproxyfen and orally administered spinosad against cat fleas (Ctenocephalides felis): Impact of treated dogs on flea life stages in a simulated home environment. Parasit Vectors. 2012; 5:192. BioMed Central Full Text
• [22]Marchiondo AA, Holdsworth PA, Fourie LJ, Rugg D, Hellmann K, Snyder DE et al.. World Association for the Advancement of Veterinary Parasitology (W.A.A.V.P.) second edition: guidelines for evaluating the efficacy of parasiticides for the treatment, prevention and control of flea and tick infestations on dogs and cats. Vet Parasitol. 2013; 194:84-97.
• [23]Veterinary International Conference on Harmonization (VICH) Guideline 43. Target Animal Safety for Veterinary Pharmaceutical Products, Step 4 draft, December, 2006.
• [24]Kramer F, Mencke N. Flea biology and control: The biology of cat flea, control and prevention with imidacloprid in small animals. Springer-Verlag, Berlin Heidelberg; 2001.
• [25]Rust MK, Dryden MW. The biology, ecology and management of the cat flea. Annu Rev Entomol. 1997; 42:451-473.
• [26]Halos L, Beugnet F, Cardoso L, Farkas R, Franc M, Guillot J et al.. Flea control failure? Myths and realities. Trends Parasitol. 2014; 30:228-233.
• [27]Dryden MW, Rust MK. The cat flea: biology, ecology and control. Vet Parasitol. 1994; 52:1-19.
• [28]Eisen RJ, Gage KL. Transmission of flea-borne zoonotic agents. Annu Rev Entomol. 2012; 57:61-82.
• [29]Dryden MW, Payne PA, Vicki S, Riggs B, Davenport J, Kobuszewski D. Efficacy of dinotefuran-pyriproxyfen, dinotefuran-pyriproxyfen-permethrin and fipronil-(S)-methoprene topical spot-on formulations to control flea populations in naturally infested pets and private residences in Tampa. FL. Vet Parasitol. 2011; 182:281-286.